CAS 13146-72-0
:3'-Desoxyinosin
- Inosine, 3'-deoxy-
- 3'-Deoxyinosine
9-((2R,3R,5S)-3-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-ol
CAS:9-((2R,3R,5S)-3-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-olReinheit:95%Molekulargewicht:252.23g/mol3'-Deoxy inosine
CAS:3'-Deoxy inosine is a Nucleoside Derivative - 3'-Modified nucleoside;3'-Deoxy nucleoside.Formel:C10H12N4O4Farbe und Form:SolidMolekulargewicht:252.23Ref: TM-TNU1498
5mgNachfragen10mgNachfragen25mgNachfragen50mgNachfragen100mgNachfragen500mgNachfragen3'-Deoxyinosine
CAS:Kontrolliertes ProduktImpurity Didanosine EP Impurity D
Applications 3'-Deoxyinosine (Didanosine EP Impurity D) is an Inosine (I661000) analog with potential use as an antileishmanial drug. Used as an inhibiting agent in studies of Trypanosoma cruzi growth inside host cells in vitro. An impurity of the antiviral drug 2’,3’-Dideoxyinosine (D440950).
References Morishige, K. et al.: Exp. Parasitol., 80, 665 (1995); Aoki, T. et al.: Adv. Exp. Med. Biol., 370, 499 (1994);Formel:C10H12N4O4Farbe und Form:NeatMolekulargewicht:252.233'-Deoxyinosine
CAS:3'-Deoxyinosine is a nucleoside analog that is used in the treatment of leukemia, lymphoma, and AIDS-related Kaposi's sarcoma. The drug inhibits DNA synthesis by inhibiting enzymes such as ribonucleotide reductase, thymidylate synthase, and dihydrofolate reductase. 3'-Deoxyinosine has minimal toxicity and may be administered orally or intravenously. It has been shown to have an inhibitory effect on the growth of skin cancer cells and leishmania parasites in cell culture. This drug also lowers blood pressure by interfering with the synthesis of angiotensin II and may be useful for treating hypertension. The drug is synthetically prepared in a laboratory by chemists.
Formel:C10H12N4O4Reinheit:Min. 95%Farbe und Form:PowderMolekulargewicht:252.23 g/molRef: 3D-ND166260
Ausgelaufenes produkt





